WAS
UTHR icon

Winch Advisory Services’s United Therapeutics UTHR Stock Holding History

Winch Advisory Services’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.71K Hold
5
– – ﹤0.01% 452
2026
Q1 		$2.96K Hold
5
– – ﹤0.01% 404
2025
Q4 		$2.44K Hold
5
– – ﹤0.01% 410
2025
Q3 		$2.1K Hold
5
– – ﹤0.01% 424
2025
Q2 		$1.44K Hold
5
– – ﹤0.01% 433
2025
Q1 		$1.54K Hold
5
– – ﹤0.01% 428
2024
Q4 		$1.76K Buy
+5
New +$1.84K ﹤0.01% 450

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Winch Advisory Services's UTHR Position: Q2 2026 in Review

Winch Advisory Services held its United Therapeutics (UTHR) position steady in Q2 2026 at 5 shares worth $2.71K. The position accounts for ﹤0.01% of the portfolio, ranked #452.

Winch Advisory Services first reported a position in UTHR in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.96K in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Winch Advisory Services held 5 shares of United Therapeutics worth $2.71K as of Q2 2026.
  • Winch Advisory Services left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Winch Advisory Services's portfolio in Q2 2026, its #452 holding.
  • Winch Advisory Services first reported a position in United Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Winch Advisory Services's United Therapeutics position peaked at $2.96K in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Winch Advisory Services's 13F filing for Q2 2026, filed 6 Aug 2026.